Martin Lagging
- Hepatology top 0.2%
- Hepatitis C virus research 86
- Liver Disease and Transplantation 13
- Hepatitis Viruses Studies and Epidemiology 9
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 61
- Hepatitis B Virus Studies 50
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 14
- COVID-19 Clinical Research Studies 8
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research 9
- Virology top 5%
Martin Lagging
114 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 121
- Hepatology 3.2k
- Epidemiology 2.8k
- Infectious Diseases 528
- Rheumatology 390
- Virology 109
Countries citing papers authored by Martin Lagging
This map shows the geographic impact of Martin Lagging's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Lagging with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Lagging more than expected).
Fields of papers citing papers by Martin Lagging
This network shows the impact of papers produced by Martin Lagging. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Lagging. The network helps show where Martin Lagging may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Lagging, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 0 | |
| 4 | 2022 | 8 | |
| 5 | 2014 | 8 | |
| 6 | 2014 | 32 | |
| 7 | 2013 | 9 | |
| 8 | 2012 | 31 | |
| 9 | 2012 | 14 | |
| 10 | 2011 | 122 | |
| 11 | 2011 | 82 | |
| 12 | Ip-10 Is Associated With Il28b Variation And Predicts The First Phase Decline Of Hcv Rna And Outcome Of Therapy In Chronic Hepatitis C | 2010 | 2 |
| 13 | 2009 | 101 | |
| 14 | 2008 | 6 | |
| 15 | 2008 | 113 | |
| 16 | 2006 | 179 | |
| 17 | 2006 | 64 | |
| 18 | 2006 | 59 | |
| 19 | 2005 | 113 | |
| 20 | 2002 | 113 |
About Martin Lagging
Martin Lagging is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Animal Science and Zoology, having authored 116 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (86 papers), Liver Disease Diagnosis and Treatment (61 papers), Hepatitis B Virus Studies (50 papers), SARS-CoV-2 and COVID-19 Research (14 papers), Liver Disease and Transplantation (13 papers), Hepatitis Viruses Studies and Epidemiology (9 papers), Systemic Lupus Erythematosus Research (9 papers) and COVID-19 Clinical Research Studies (8 papers). The work is most often cited by research in Hepatology (3.2k citations), Epidemiology (2.8k citations), Infectious Diseases (528 citations), Rheumatology (390 citations) and Virology (109 citations). Martin Lagging has collaborated with scholars based in Sweden, United States and Italy. Frequent co-authors include Keith Meyer, Gunnar Norkrans, Johan Westin, Ranjit Ray, Rune Wejstål, Kristoffer Hellstrand, Magnus Lindh, Stefan Zeuzem, Francesco Negro and Avidan U. Neumann. Their work appears in journals such as Journal of Hepatology, PLoS ONE, Scandinavian Journal of Gastroenterology, Journal of Viral Hepatitis and Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.